GSK
2021 — 2025
At GSK, Commercial and Medical organisations each developed their own design systems independently, leading to naming conflicts, duplicated effort, and fragmented user experiences across products. I led the initiative to consolidate these separate systems into a single unified platform called Omni — a design system that would serve 10+ product teams across healthcare, pharma, and internal tooling.
Beyond naming, I designed the visual identity for the Omni design system itself. This included the Omni logotype, a colour system that distinguished each sub-system while maintaining visual cohesion, and a documentation site that made the system accessible to designers and engineers with no prior design systems experience.
Scaling a design system inside a regulated pharmaceutical company required navigating stakeholder expectations across legal, brand, and compliance functions. I introduced a federated contribution model with three tiers: global primitives owned by the core team, domain components co-owned with business unit leads, and local patterns teams could develop independently using system primitives.
How I developed the naming convention system for Commercial and Medical Design Systems to bring them under one roof.
Building a centralised hub for all Omni design systems with research-driven information architecture — card sorting, tree testing, and a consistent homepage structure used across all markets.